BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

907 related articles for article (PubMed ID: 8821539)

  • 21. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal delta 2-, but not delta 1-, mu-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat.
    Tseng LF; Tsai JH; Collins KA; Portoghese PS
    Eur J Pharmacol; 1995 Apr; 277(2-3):251-6. PubMed ID: 7493616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the delta-opioid receptor in (1DMe)NPYF mediated antinociception.
    Xu M; Kontinen VK; Panula P; Kalso E
    Peptides; 2001 Jan; 22(1):33-8. PubMed ID: 11179595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective delta-opioid receptor agonist.
    Kalso EA; Sullivan AF; McQuay HJ; Dickenson AH
    Eur J Pharmacol; 1992 May; 216(1):97-101. PubMed ID: 1326441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.
    Hong M; Sutak M; Jhamandas K
    Br J Pharmacol; 1993 Apr; 108(4):1137-42. PubMed ID: 8485623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid receptors mediating antinociception from beta-endorphin and morphine in the periaqueductal gray.
    Smith DJ; Robertson B; Monroe PJ; Taylor DA; Leedham JA; Cabral JD
    Neuropharmacology; 1992 Nov; 31(11):1137-50. PubMed ID: 1335557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synaptic actions of neuropeptide FF in the rat parabrachial nucleus: interactions with opioid receptors.
    Chen X; Zidichouski JA; Harris KH; Jhamandas JH
    J Neurophysiol; 2000 Aug; 84(2):744-51. PubMed ID: 10938301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A lack of supersensitivity to opioid receptor agonists following chronic spinal opioid receptor antagonist administration in the rat.
    Keck BJ; Stafinsky JL; Uram M; Crisp T
    Gen Pharmacol; 1995 Jan; 26(1):161-8. PubMed ID: 7713356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat.
    Tiseo PJ; Yaksh TL
    Eur J Pharmacol; 1993 May; 236(1):89-96. PubMed ID: 8391455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
    Negri L; Noviello L; Noviello V
    Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential involvement of opioid receptors in intrathecal butorphanol-induced analgesia: compared to morphine.
    Wongchanapai W; Tsang BK; He Z; Ho IK
    Pharmacol Biochem Behav; 1998 Mar; 59(3):723-7. PubMed ID: 9512078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid effects on spinal [3H]5-hydroxytryptamine release are not related to their antinociceptive action.
    Monroe PJ; Kradel BK; Smith DL; Smith DJ
    Eur J Pharmacol; 1995 Jan; 272(1):51-6. PubMed ID: 7713149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats.
    Kotlinska JH; Gibula-Bruzda E; Witkowska E; Chung NN; Schiller PW; Izdebski J
    Peptides; 2013 Jan; 39():103-10. PubMed ID: 23183627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.